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1. Introduction 
Attention deficit/Hyperactivity (ADHD) disorder, a neuropsychiatric disorder characterized 
by inattention, hyperactivity and impulsivity, has been precisely described by the American 
Psychiatric Association (APA, DSM-IV, 2000). According to the diagnostic criteria these main 
symptoms must appear before the age of 7 years, be present for at least 6 months, be evident 
in at least two settings, and the impairment must contribute to social, academic, or 
occupational dysfunction. An increasing number of patients, mostly children, are diagnosed 
with ADHD. Recent studies focusing on the epidemiology of the disorder, reported variable 
prevalence of ADHD in childhood that reached in some studies the percentage of 14% 
(Barbaresi et al, 2004; Froehlich et al, 2007; Pliszka, 2007; Merinkagas et al, 2010; CDC, 2010). 
It is estimated that 30-70% of children with ADHD continue to experience ADHD symptoms 
into adulthood (Vollmer, 1998; Wender, 1997; Mannuzza et al, 1991; Elia et al, 1999). 
The therapeutic approach of ADHD includes several treatment modalities (pharmacotherapy, 
behavioral, psychological and educational interventions). The choice of treatment depends 
mainly on the patient's characteristics such as age at diagnosis, the presence of co-morbid 
conditions and the therapeutic goals. Behavioral interventions alone have not been effective in 
ameliorating the core symptoms of ADHD to a significant extent (The Multimodal 
Treatment study of Children with ADHD [MTA], 1999; Brown et al, 2005). Their main 
contribution is the improvement of the behavioral problems that frequently accompany 
ADHD (Kolko et al, 1999; Pelham et al, 1998). Pharmacotherapy is one of the most 
efficacious treatment approaches both in children and adolescents. Stimulants have been for 
many years the first-line treatment for ADHD with a response rate of approximately 70% or 
more when patients are strictly complying with the treatment (MTA, 1999; Miller et al, 1998; 
Schachter et al, 2001). Atomoxetine seems to be about equally effective to stimulants, even 
though in a recent meta-analysis it was reported that stimulants (especially the long-lasting 
ones) demonstrated greater efficacy than atomoxetine during the short duration of 
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treatment evaluation (≥ 2 weeks) (Wang et al, 2007; Faraone & Glatt, 2010). In most of the 
patients it is beneficial to combine medications with psychological and educational 
interventions especially when there is a suboptimal response to pharmacotherapy, a co-
morbid disorder and stressors in the family. A systematic review of 11 randomized 
controlled trials, including 428 children 5-18 years old, demonstrated that combination 
therapy with methylphenidate and behavioral/psychological treatments significantly 
improved ADHD behaviors, symptoms, and measures of academic achievement compared 
to behavior/psychological treatments alone (Lord & Paisley, 2000). Guidelines on the 
management of ADHD in children include all aforementioned options, alone or in 
combination (American Academy of Pediatrics, 2001; Golgman et al, 1998; Dulcan, 1997).  
The next important issue on ADHD management is the duration of the positive effects of 
these interventions. For example, the long term efficacy of medications has not been 
demonstrated. The Multimodal Treatment Study of Children with the combined type of 
ADHD (MTA study), which compared pharmacotherapy- short acting methylphenidate - 
versus behavioral therapy or their combination or the standard care provided by 
community providers, reported in 2004 that treatment with stimulants for 24 months had a 
reduced effect, as compared to the effectiveness at 14-months published by the same group 
(MTA, 2004). At 3 years of follow-up of the same patients, the advantage of medications in 
comparison to all other treatment options disappeared although in all treatment groups an 
improvement on ADHD symptoms was observed compared to baseline (Jensen et al, 2007). 
The possible explanations of the loss of the pharmacotherapy advantage over all other 
treatments were an age-related decline in ADHD symptoms, changes in the intensity of 
medical management, and alternating periods of treatment/no-treatment after the 14 month 
study period. In 2002, Monastra et al demonstrated that patients treated with short acting 
stimulants (Ritalin) lost the benefits derived from the drugs one year after cessation of the 
drug (Monastra et al, 2002). Similar results had also been presented on the long term 
effectiveness of atomoxetine, 9 months after drug discontinuation (Michelson et al, 2004). All 
these observations along with the fact that 25–40% of children with ADHD do not respond 
to medications and other conservative treatments makes the research on alternative 
therapeutic approaches an interesting field (MTA, 1999; Pelham et al, 1998; Miller et al, 1998; 
Swanson et al, 1993; Barkley, 1998). 
Neurofeedback, a form of biofeedback linked to brain activity, was first described as an 
option for ADHD treatment in the mid-1970's, by Lubar and Shouse (Lubar & Shouse, 1976). 
The hypothesis behind the use of this method is that it may enable the user to modify 
brainwave activity in order to improve attention, reduce impulsivity and control 
hyperactive behavior. This modification is based on self-regulation of neuronal oscillations 
recorded by EEG. The goal is to enhance some types of EEG activity or reduce some others 
in one or more frequency bands by visual or auditory feedback; for example in ADHD, the 
aim is to enhance beta activity and to inhibit theta activity. There are two major categories of 
neurofeedback training protocols: one that uses frequency bands of the brain activity and a 
second which involves training of slow cortical potentials (SCPs), with the first being far 
more studied than the latter (Vernon et al, 2004). Concerning the first training strategy, three 
parameters are usually used in children with ADHD: theta frequency (4-8 Hz), beta 
frequency (15-20 Hz) and sensorimotor rhythm (SMR) (12-15 Hz). The target of the patient 
under training is to decrease the power of theta activity and/or to increase power of beta 
www.intechopen.com
The Effect of Psycho-Educational Therapy 
on Electroencephalographic Biofeedback Scores in Attention Deficit Hyperactivity Disorder 
 
289 
activity and SMR activity, in order to improve attention skills. Research protocols usually 
combine two or even more parameters. SCPs were first described by Heinrich et al in 2004 
(Heinrich et al, 2004). They are event-related shifts of cortical activity lasting from several 
hundred milliseconds to several seconds (Birbaumer et al, 1990). The training of the SCPs 
involves an effort to increase positivity or negativity over sensorimotor cortex, in order to 
enable the subject to control cortical regulation and to allocate resources efficiently, 
functions that are supposed to be impaired in ADHD (Sergeant, 2000; 2005).  
Several studies have demonstrated that neurofeedback has a favorable effect on ADHD 
symptomatology and cognitive function, as compared to both placebo and 
psychostimulants, regardless of the protocol used (Monastra et al, 2002; Arns et al, 2009; 
Gevensleben et al, 2009a, Drechsler et al, 2007; Heinrich et al, 2007; Levesque et al, 2006; 
Rossiter, 2004; Fuchs et al, 2003). Furthermore, in 2010, Gevensleben H et al published a 6 
months follow-up study providing evidence for long-term benefits of neurofeedback 
training in children with ADHD (Gevensleben et al, 2010).  
In spite of these promising results considerable controversy continues to surround 
neurofeedback as a therapeutic option for ADHD patients. The skepticism towards this type 
of training is based mostly on methodological shortcomings of the published research. Small 
sample size, non-randomized group assignment, and control conditions that do not control 
for confounding factors since they lack a double-blind setup are the major design problems, 
that are not easy to overcome (Heinrich et al, 2007). It is questionable whether behavioral 
improvements after neurofeedback training can be related to the improved cortical 
regulation or rather to non-specific treatment effects such as invested time and attention, 
therapist- patient interaction, expectancies, changes in the parental attitude, enhanced 
awareness of the problem or maturation-related factors. Since systematic reinforcement and 
a positive relationship to a therapist are integral parts of the neurofeedback training and of 
any other behavioral intervention especially with children, selective effects of the 
neurofeedback are difficult to isolate (Drechsler et al, 2007). The best way to resolve this is 
the correct choice of a control group. However, the implementation of a control condition 
for neurofeedback training is also difficult. For research purposes, the best control condition 
would be a placebo neurofeedback condition in which provided feedback is similar to 
neurofeedback, but not related to the child’s own brain activity. The main advantage of this 
type of control condition would be that it could allow participating children, parents and 
trainers to be blinded for group allocation; thus confounding factors would be minimized. 
However, implementing a placebo control condition in a randomized controlled trial may 
lead to ethical concerns, mostly because this design also involves withholding evidence-
based treatment (LaVaque & Rossiter, 2001; Strehl et al, 2006). Moreover, it has been argued 
that placebo neurofeedback training may not be feasible since positive or negative 
therapeutic effects will be perceived by the patient or the therapist (Kotchoubey et al, 2001). 
Additionally, in a placebo-controlled study it is important to monitor adverse events during 
the training period in order to test the safety of the placebo condition, that could potentially 
represent a problem in this type of setting (Birbaumer et al, 1992). For these reasons, the use of 
a placebo-control study design is rather limited. To our knowledge, only one double-blind 
placebo-controlled trial has already been published (Lansbergen et al 2011). Other types of 
control groups that have been utilized are a waiting list control group (Heinrich et al, 2004; 
Levesque et al, 2006), children undergoing group therapy (Drechsler et al, 2007), and a group 
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undergoing computerized attention training (Gevensleben et al, 2009a). Group therapy and 
computerized attention training may effectively control for unspecific effects such as invested 
time and treatment expectancies. Waiting list, on the other hand, may introduce bias because 
of maturational changes, multiple testing or changed parental attitudes (Drechsler et al, 2007). 
Finally, it has also been argued that neurofeedback training protocols may have a selection 
bias by design. Given the financial investment and time commitment required for the 
completion of neurofeedback training program, the majority of children who receive such a 
treatment are most likely from “stable, upper socioeconomic households, who may have 
simply improved over time because of their advantaged position” (Baydala & Wikman, 2001). 
Nevertheless, the evidence provided by the most recent and better designed studies is 
considered to be substantial if not yet conclusive and the use of neurofeedback training for 
ADHD had gained empirical support. In addition to the accumulating evidence on the 
effectiveness of neurofeedback in patients with ADHD, it is now suggested that this 
treatment may be integrated in a multimodal therapeutic approach (Gevensleben et al, 
2009a; MTA, 1999). The combination of neurofeedback with standard therapies such as 
pharmacotherapy, and/or social skills training and parental interventions could result in 
additional improvements not only to the primary symptoms of the disorder but to other 
related areas such as learning, behavior and emotional stability. The aim of this study was to 
explore the interactions between neurofeedback and a program of psychological and 
educational interventions prescribed for the management of ADHD. Our hypothesis was 
that the combination of these treatments may induce larger improvements of the examined 
electrophysiological parameters studied than neurofeedback alone, suggesting a synergistic 
effect of these two treatment modalities on brain training. 
2. Methods 
2.1 Patients 
Children consecutively evaluated in the outpatient Child Neurology clinic with an ADHD 
diagnosis according to DMS IV criteria were considered as candidates for this study. Only 
children that scored within the normal IQ range (IQ>80), according to WISC III, were 
included in the study. The presence of co-morbidities other than learning disorders was an 
exclusion criterion. After an initial evaluation by the clinical psychologist, the teacher of 
special education, the speech therapist and the occupational therapist, 30 children who 
fulfilled our inclusion and exclusion criteria were recruited for this study. All of them had 
learning difficulties in reading and writing. 
2.2 Interventions 
Two kinds of therapeutic interventions were proposed with the intention to be combined: a 
psycho-educational program (2 hours/week) and a biofeedback training protocol (2 
hours/week). The combined program was not accepted by several families due mostly to 
financial reasons (the biofeedback was covered by most insurance agencies), or due to time 
restrictions. As a result we ended up with two groups: the first group included 15 children 
who attended the biofeedback program only (NF group) whereas in the second group 
(n=15) children were treated with both biofeedback and psycho-educational treatment 
(NF+PSE group).  
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2.2.1 Neurofeedback 
The biofeedback protocol that was used was the Sensorimotor rhythm (SMR) 
enhancement/theta suppression. This is based on the concept that improved attention and 
behavioral control is achieved when the child learns to reduce the production of theta and 
increase the production of the 12–15 Hz sensorimotor rhythm generated over the electrodes 
C3 or C4 that are positioned over the motor cortex. EEG recordings were obtained from one 
active site (C3 or C4), referenced to linked earlobes. Theta/Beta ratio was measured before 
the training initiation, after the 20th session and after the 40th session. In each of these 
instances, the ratio was obtained in three conditions: Eyes closed, eyes opened and during 
an attentional task (eyes fixed task). Mean values were calculated over these three 
conditions. 
The neurofeedback training program was designed to last for 40 sessions. Each 
neurofeedback session lasted for about 45 minutes. Each child worked individually under 
the supervision of a psychologist (certified neurofeedback trainer). Children were seated 
facing a computer screen. Once the electrodes were synchronized with the trainer’s 
computer, the children were directed to start playing a computer game. In all the 
neurofeedback games, the children were asked to move a target, by using their gaze and by 
remaining concentrated on the target. For as long as the children remained with their gaze 
perfectly concentrated on the target, they gained points and completed the game by 
fulfilling the defined goal. Visual (animated figures) feedback was provided based on the 
patient’s success in controlling a) the amplitude in microvolts of theta or sensorimotor 
rhythm (SMR) or b) the percentage of time that theta rhythm was below pre-treatment 
threshold or SMR was above pre-treatment threshold. Patients were informed via auditory 
(tone) and visual feedback when they produced 0.5 seconds of desired EEG activity. By the 
end of each game, the children got a sum of points, depending on their performance. The 
goal for each child was to achieve a score that is closer to what is considered appropriate for 
his/hers age level. Throughout a session the children played as many as 6 games.  In 
between the games, they received immediate feedback on their performance so that they 
could then proceed to adjustments of the attention level. After a break of 1 to 2 minutes, they 
proceeded to the next one. This process was repeated throughout the whole session. At the 
end of each session, children and parents were informed on the total score. 
2.2.2 Psycho-educational 
This was based on the cognitive-behavioral approach for children with ADHD and was 
scheduled for 2 hours/week right after the neurofeedback session. The intervention 
program addressed both reading and writing difficulties and at the same time the 
specialized therapist provided support to the children who due to their learning difficulties 
struggled at school.  Furthermore, both patients and parents received practical counselling 
with regard to time organisation and scheduled activities management. 
2.3 Statistical analysis 
Mean Theta/Beta ratio scores at the first session and after the 20th and the 40th (last) session, 
were tested for normality using Shapiro-Wilk distributional test. Normal data were 
expressed as mean values ± standard variation (SD), whereas non normal data as median 
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values (25th -75th percentile). The comparison of mean neurofeedback scores between the 
two treatment options was assessed with t-test when normally distributed or with Mann-
Whitney U Test when non-normal. Categorical variables were compared with Chi square 
test or Fisher's exact test according to number of observations per cell. P-values for the tests 
applied in two different occasions (after the 20th and after the 40th session) were corrected 
with Bonferroni Correction for multiple comparison test, in order to reduce Type I error. 
Finally, mixed effects model was applied to test the longitudinal evolution of mean 
Theta/Beta ratio, taking into account the therapy group in which each patient is assigned. In 
these models, patient and number of sessions were treated as random variables. 
3. Results 
The patients (N=30, 15 boys and 15 girls) had a mean age of 7 years 7 months (± 1 year 2 
months). The two groups (NF and NF+PSE group) consisted of 15 patients each and they 
were similar in terms of age and sex. All patients followed their treatment consistently and 
there were no dropouts. 
At baseline (first neurofeedback session), mean Theta/Beta ratios were not significantly 
different between the two therapy branches (3.13 ± 0.02 for the NF+PSE group versus 3.10 ± 
0.2 for the NF group, p-value=0.265). Two out of the patients of the NF group managed to 
obtain the target ratio (< 3) already during their first neurofeedback training session.  
 
 
Theta/Beta ratio at 
First session 
Theta/Beta ratio 
after 20th session 
Theta/Beta ratio after 40th 
session 
NF group 3.10 ± 0.08 3.03 ± 0.10 2.95 ± 0.13 
NF+PSE 
group 
3.13 ± 0.06 3.05 ± 0.06 2.94 ± 0.06 
Table 1. Mean Theta/Beta values for children the two treatment groups at discrete 
observation times 
Table 1 displays mean Theta/Beta ratios for children in both treatment groups. All patients 
presented a decrease in Theta/Beta ratio values during their treatment. According to the 
mixed effects model applied, this observed decrease was significant as treatment evolved (p-
value <0.001). However, the size effect of time elapsed was quite small with the ratio after 
the 20th session being as much as 0.078 units lower than its initial value, and after the 40th 
session being as much as 0.172 units lower than its initial value. Similarly, age of patients 
was a significant predictor of mean Theta/Beta values obtained (p-value <0.001). More 
specifically, children 8 or more years old had slightly lower mean values than those younger 
than 8 years, adjusted for  treatment group and time of observation (coefficient = -0.082, 95% 
CI = between  -0.127 and -0.038).  
On the other hand, mean values of Theta/Beta ratios were not significantly different 
between the two treatment groups, at a precise time point (after the 20th or after the 40th 
neurofeedback session – p-value=0.841). These results are graphically demonstrated in Fig 1. 
However, when we compared the percentages of patients who succeeded to obtain the 
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target ratio between the therapy groups, we were able to display that significantly more 
patients of the NF+PSE group reached the target, as compared to the NF group only after 
the 40th session (14 versus 6 patients respectively, p-value=0.006). The difference after the 
20th session was not significant (4 patients of the NF+PSE group versus 4 patients of the NF 
group, p-value=0.841) (Fig 2). In this analysis, we omitted the two patients of the NF group 
who had a successful first session, although their inclusion does not really affect the results. 
 
 
Fig. 1. Longitudinal evolution of mean Theta/Beta ratio for patients of the two treatment 
groups 
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Fig. 2. Frequency of children who had achieved the goal of Theta/Beta <3 at the first, after 
the 20th and after the 40th session 
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4. Discussion 
The main result in this study was that the addition of psycho-educational treatment to EEG 
biofeedback resulted in normalization of Theta/Beta ratio and thus in reducing the slowing 
of the frontal brain activity. To our knowledge, this is the first study to report changes on 
neurofeedback studied parameters in relation to the psycho-educational intervention.  
Up to the present time, only a few studies have assessed the effects of pharmacotherapy, 
mostly psychostimulants, on EEG patterns in children with ADHD. It has been 
demonstrated that the use of psychostimulants produce a decrease in Theta/Beta ratio in 
children with ADHD, to the point of reaching normal values and this was more prominent 
in the right hemisphere (Clarke et al, 2001a; Clarke et al, 2007; Dixit et al, 2002; Kerdar et al, 
2007, Hermens et al, 2005). In their study in 2005, Song DH et al demonstrated that the 
treatment with methylphenidate induced an increase in Theta/Beta ratio in the right frontal 
and parieto-occipital region in 20 boys with ADHD, during continuous performance test 
(CPT) and not in resting states (Song et al, 2005).  
When used as part of multimodal treatment in ADHD the psycho-educational intervention 
aims to maximize the likelihood of the child’s academic success by developing areas of 
strength, by adapting to special needs and by remediating knowledge and skill deficits 
(William & Smucher, 2001). There is great variability concerning the form of psycho-
educational intervention in bibliography. It may include informative sessions on ADHD, 
behavioral strategies (parental training, child self-control instruction training, school-based 
techniques, family counseling) and/or educational packages in combination with behavioral 
techniques (Montoya et al, 2011).  
In the present study, we were able to demonstrate that the psycho-educational program 
which was added to the treatment of ADHD children could enhance the effect of the 
neurofeedback protocol used. We have shown that the percentage of patients who reached 
EEG activity normalization was higher in the NF+PSE compared to the NF group. However, 
when we compared the longitudinal evolution of Theta/Beta ratio between the treatment 
groups, the psycho-educational program did not have an effect. Taking into account the fact 
that all children learned to reduce brain slowing but not all of them achieved normal 
Theta/Beta ratios during the 40 sessions programmed, it can be postulated that the 
implementation of a psycho-educational program may accelerate the neurofeedback 
training process. Whether the effect of the psycho-educational program is modified by other 
unspecified factors needs to be further studied . 
One factor that has been demonstrated to be an important moderating factor of behavior at 
home, especially in children treated with neurofeedback, was parental support. In the study 
of Monastra et al,  when “systematic” approaches towards parent mediated reinforcement  
strategies were used with patients treated with both neurofeedback and standard therapies, 
improved behavioral ratings were demonstrated not only at school environment but also at 
home, even when medication was discontinued (Monastra et al, 2002). On the contrary, 
when electrophysiological parameters were examined, as in the study of Drechsler et al, 
there was no evidence of a direct influence of parent directed approaches on successful 
cortical control, as 50% of the children who performed well in neurofeedback training and 
66% of those who performed bad, belonged to the high parental support group (Drechsler et 
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al, 2007). In the current study, we did not examine parental support as a factor that could 
affect the results of the prescribed treatment. 
Table 1 reports absolute values of Theta/Beta ratios on three different occasions: at first 
session, after the 20th session and after the 40th session. To our knowledge, only few 
neurofeedback studies focus on brain activity modification itself and EEG data are rarely 
available. Initial values for Theta/Beta ratio at first session were not similar to those 
reported by Monastra et al in 1999 for a group of ADHD children of the same age (Monastra 
et al, 1999).  In this study, authors used a Theta/Beta value that was at least 1.5 SD higher 
than the value reported for normal age peers as a cutoff point for ADHD diagnosis. In the 
current study, mean Theta/Beta values at first session (practically before training) were 
lower as compared to those reported in the aforementioned study for children with ADHD 
but above the threshold for normal children 6-11 years old (which was set at the value of 3). 
On the other hand, the Theta/Beta ratios reported by Song et al in 20 patients with a mean 
age of 8.6 years (1.4 years) were lower than those presented in our study, in all brain regions 
that were examined (Song et al, 2005). 
One explanation for this discordance in Theta/Beta values may be due to the positioning of 
electrodes.  In some studies focusing on neurofeedback methodology, it was observed that 
when electrodes were fixed frontally, where more theta and less beta activity in patients 
with ADHD is found, then artifacts by eye movements may be a significant risk (Mann et al, 
1992; Lubar et al, 1995; Chabot & Serfontein, 1996). For this reason it is suggested that 
electrodes are placed in a more central position at C3f (= halfway between C3 and F3) and 
C4f (= halfway between C4 and F4) (Monastra et al, 1999). In the current study electrodes 
were positioned at C3 or C4 positions (a bit posteriorly in relation to the positions described 
previously), whereas in the study of Song et al Theta/Beta ratios were recorded in all 30 
regions defined by the International 10/20 system but not over C3-C4 or C3f-C4f (Song et al, 
2005; Monastra et al, 1999). A second explanation may be the difference in the methodology 
used and more precisely in the calculation of the mean Theta/Beta ratio. In both the 
aforementioned studies and in the current study, the Theta/Beta ratio was measured in 
different conditions (performance tasks, resting states, eyes open/closed) and therefore the 
produced mean values are not expected to be similar. 
Furthermore, in the present study we did not make a discrimination of the ADHD type. The 
composition of the study group in our study could also account for the observed differences in 
the Theta/Beta values from the study of Monastra et al (Monastra et al, 2002). According to 
some authors children with ADHD–Combined Type may exhibit more absolute and relative 
theta activity, and higher Theta/Alpha and Theta/Beta ratios when compared to those with 
ADHD–Inattentive type (Clarke et al, 1998; Clarke et al, 2001b; Clarke et al, 2003). Although 
these results were not reproduced by other authors, they may suggest that children with 
ADHD– Combined Type show the classic pattern of greater underarousal and maturational 
delay more so than the children with ADHD– Inattentive type. In contrast, the latter group of 
patients exhibited more relative alpha activity in the posterior regions than those with 
ADHD–Combined Type, which is consistent with reports of slower cognitive processing and 
increased rates of daydreaming among these kids (Monastra et al, 2001; Loo & Barkely, 2005). 
As we have shown, Theta/Beta ratio decreased substantially, from the first to the 40th 
session. Similar results were reported previously (Monastra et al, 2002; Thompson L & 
Thompson M, 1998; Lubar et al, 1995; Loo & Barkley, 2005; Gevensleben et al, 2009b; Leins et 
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al, 2007).  In the first of these studies, patients who underwent neurofeedback training 
presented a significant reduction on their Theta/Beta ratio values from above 5.03 
(pretreatment) to less than 3 (post-treatment) (Monastra et al, 2002). A decrease in 
Theta/Beta ratio was also observed in a randomized study published in 2009 by 
Gevensleben and colleagues (Gevensleben et al, 2009). In this study, the modification of EEG 
activity demonstrated in 72 children with ADHD was attributed to a marked decrease of 
theta activity in posterior midline position. The findings of Leins et al are also in accordance, 
although they used a different approach (Leins et al, 2007). They studied Theta/Beta ratios 
in activation and in deactivation tasks and in feedback and transfer conditions, in order to 
produce similar states with the SCP training program. They observed that Theta/Beta ratio 
changed significantly in deactivation tasks but not in activation tasks and only in feedback 
conditions. In activation tasks, a decrease in Theta/Beta ratio was observed already within 
the first sessions of the treatment but, in the end, it did not reach significance. It should be 
also noted that in the current study just as in the study published in 2002 by Monastra et al, 
Theta/Beta values by the end of neurofeedback training were similar to values produced by 
non-ADHD age peers. However, this finding was not reproduced in the study of Carmody 
et al, in which normalization of spontaneous EEG after frequency neurofeedback training 
was not found (Carmody et al, 2001).  
Another important aspect of the current study is that all members of the study sample 
proved to be capable of altering their brain wave frequency.  The percentage of patients who 
learn how to increase cortical activity varies across the studies published. In most of them, 
this percentage was quite high. As in the present study, Lubar et al reported, in a part of 
their research, that all patients managed to slow cortical activity (Lubar et al, 1995). In 
support of these data, the majority of patients in the study of Lansbergen et al learned to 
increase SMR and decrease theta activity (Lansbergen et al, 2011). Nevertheless, it has also 
been reported that some participants fail to obtain satisfactory training results during EEG 
feedback or transfer (Drechsler et al, 2007; Lubar et al, 1995; Strehl et al, 2006; Kropotov et al, 
2005).  This result was mostly observed in training SCPs protocols and it was attributed to 
the protocol itself since the SCP training, which is rather strategic in nature and prone to 
artifacts, may be more difficult for children with ADHD than a neurofeedback training 
based on frequency ratios (Drechsler et al, 2001). 
Finally, it was shown that the effect of psycho-educational program on neurofeedback 
parameters is present only after 40 sessions. In most studies, it seems that a total of 40 
sessions is needed in order to achieve improvements in ADHD symptoms and in daily 
functioning. In the study of Monastra et al, the EEG neurofeedback training was stopped 
when participants obtained Theta/Beta ratio in the normal range for age (within 1.0 SD of 
age peers) for at least 40 min and for 3 consecutive treatment sessions (Monastra et al, 2002). 
The average number of sessions needed to reach this goal was 43 (range: 34–50). However, 
fewer sessions may also be enough to produce the desirable effect. In the study of 
Gevensleben et al, the alteration of brain activity required only 18 sessions (Gevensleben et 
al, 2009b). Similar were the results of Leins et al who suggested that patients learn to alter 
EEG activity at a very early stage of the training but they don't show any improvement 
during the following sessions (Leins et al, 2007). When it comes to long-term benefits from 
neurofeedback, Fox et al suggested that for a long lasting change on EEG frequencies, many 
sessions, up to 60, may be required, even though it was demonstrated that 30% of patients 
treated with ADHD are capable of changing their brain waves frequency for a long time 
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after as few as 20 sessions of neurofeedback training (Fox et al, 2005; Rossiter & LaVaque, 
1995). Importantly, the desired improvement on behavioral rating scales and the Test of 
Variables of Attention (TOVA) was also achieved in 20 sessions (Rossiter & LaVaque, 1995). 
The current study has several limitations. The main ones are the relatively small number of 
participants, the study design and the absence of follow-up data. Patients included in the 
research are not randomly assigned to the treatment groups and although they are similar 
for age and sex, they are not matched. Additionally, the procedure is not blinded, which in 
combination with the absence of randomization or matching, may allow confounding 
factors (such as parental expectation and style) to interfere with the results. Consequently, 
our results may not be easily generalized. Furthermore, although it was shown that the 
addition of a psycho-educational program does induce greater changes on Theta/Beta ratios 
towards normalization than neurofeedback alone, this effect is only apparent immediately 
after the completion of the training. We did not examine if that effect retained in the long 
term. If that proved to be true, it would greatly support the simultaneous use of 
neurofeedback with other behavioral interventions, based on a long standing, and hopefully 
permanent brain activity modification. 
Another limitation of the current study is the lack of data concerning changes on patients’ 
clinical characteristics. However, at this point of our investigation, the study was not  
designed  to examine the correlation between changes presented in Theta/Beta ratios and 
behavioral alterations or if the addition of the psycho-educational program produced 
greater improvements on ADHD symptoms, in comparison with the presumed improvements 
due to neurofeedback training alone. In 1995, Lubar and coworkers found that all children 
who undertook the neurofeedback training showed improvements in behavior and 
attention, although not statistically significant. These improvements were present in both 
children who managed or did not manage to alter brain activity (Lubar et al, 1995). 
However, more recent research demonstrated that the extent of ADHD symptoms 
improvement along with the extent of neurophysiological parameters’ improvement is 
positively correlated to the degree to which the patient is able to learn to alter his/her brain 
activity during training sessions. This correlation suggests that functional improvement is 
based on “the specific action of feedback-guided learning.”(Hirshberg, 2007; Gruzelier & 
Egner, 2005). 
5. Conclusion 
To conclude, the decision to combine a psycho-educational intervention with neurofeedback 
in management of children with ADHD may be an advantageous option. The psycho-
educational program seems to accelerate the ability of the child to alter brain activity and to 
reach the normal range of values of electrophysiological parameters. Further research 
should be focused on the clarification of variables involved in this bi-modal approach e.g. 
the exact type of the psycho-educational intervention applied, with detailed description of 
patient and parent derivatives and the best neurofeedback protocol for each ADHD 
subtype, with the goal to achieve the maximum effect not only on the brain activity but also 
on the ADHD symptoms. It would also be of importance to examine long term effects of the 
two treatments, on brain electrophysiolology and on clinical parameters such as ADHD 
symptoms, academic achievement and even quality of life.  
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